Zobrazeno 1 - 4
of 4
pro vyhledávání: '"K J Wait"'
Four commercial enzyme immunoassays (EIAs) for the detection of Clostridium difficile toxin A have recently been developed and marketed (Premier, Meridian Diagnostics, Cincinnati, Ohio; VIDAS, bioMerierux Vitek, Inc., Hazelwood, Mo.; Tox-A-Test, Tech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d67b9fd0b4c8e7a82d6aa94178bda5d
https://europepmc.org/articles/PMC266145/
https://europepmc.org/articles/PMC266145/
Publikováno v:
Archives of pathologylaboratory medicine. 117(5)
A commercially available enzyme immunoassay (EIA) for the detection of Clostridium difficile toxin A (Premier Toxin A EIA, Meridian Diagnostics, Cincinnati, Ohio) was compared with tissue culture cytotoxicity assay, enterotoxigenic culture, and latex
Publikováno v:
Archives of pathologylaboratory medicine. 116(5)
We compared two Clostridium difficile latex agglutination tests, Meritec from Meridian Diagnostic (Cincinnati, Ohio) and CDT from Becton-Dickinson (Cockeysville, Md), on 289 specimens submitted for tissue culture cytotoxicity using MRC-5 cells. When
Autor:
W Gade, M Pinilla, W F Kelly, K J Wait, L S Babcock, S W Hinnefeld, R L Kaplan, D Greer, Peter H. Gilligan
A new enzyme immunoassay (EIA), PREMIER Cryptococcal Antigen, was compared with latex agglutination (LA) for the detection and quantitation of circulating capsular polysaccharide antigen from Cryptococcus neoformans. The clinical evaluation of PREMIE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fbd5d9c5548ee047dc442b179a0b69d
https://europepmc.org/articles/PMC270172/
https://europepmc.org/articles/PMC270172/